trastuzumab emtansine (kadcyla) Report issue

Biologics mAb ADC Approved FDA First in Class Fast Track FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$149.8940 - $180.0850

VA FSS

$201.3233 - $241.5885

AUS PBS

$1273.8334 - $2038.1241

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ado-trastuzumab emtansine 20 mg / 1 mL (1 mL INJECTION) $149.8940 VA Big4
  • KADCYLA (15)
    		•  Genentech USA
    ado-trastuzumab emtansine 20 mg / 1 mL (1 mL INJECTION) $180.0850 VA Big4
  • KADCYLA (20)
    		•  Genentech USA
    ado-trastuzumab emtansine 20 mg / 1 mL (1 mL INJECTION) $201.3233 VA FSS
  • KADCYLA (15)
    		•  Genentech USA
    ado-trastuzumab emtansine 20 mg / 1 mL (1 mL INJECTION) $241.5885 VA FSS
  • KADCYLA (20)
    		•  Genentech USA
    trastuzumab emtansine 100 mg (INJECTION) $1273.8334 AUS PBS generic
  • Kadcyla (1)
    		•  Roche Products Pty Ltd
    trastuzumab emtansine 160 mg (INJECTION) $2038.1241 AUS PBS generic
  • Kadcyla (1)
    		•  Roche Products Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue